Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy

Authors: Edurne Arriola, Ignacio Casarini, Mustafa Özgüroğlu et al.
Publication: European Journal of Cancer
Published: Jun 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Modeling the adoption of E-Procurement and Technology, Marketing and Social media bi-Products from Greek businesses and their effect on electronic sales

John Hlias Plikas, Alexandros K. Nasiopoulos et al. - Jul 2116

Read More
Approaching Reading Clubs from a historical and sociological perspective

Georgios Bikos, Panagiota Papadimitriou - Dec 2115

Read More
Individual and contextual variables affecting entrepreneurship, innovation and application of new technologies in Greece. Case study from the Greek tourism and transport sector

Vicky Katsoni, Alexandros Sahinidis - Dec 2115

Read More
Barriers to the Teaching of Skills in the Greek Higher Education Accounting Courses: Insight from Accounting Teachers

Sofia Asonitou - Oct 2115

Read More
When political marketing strategy ignores delivery: Lessons from the Greek experience

Iordanis Kotzaivazoglou - Jul 2115

Read More